Polypoidal Choroidal Vasculopathy: Faricimab Injections

We are studying the effects of faricimab injections on vision improvement in Caucasian patients with polypoidal choroidal vasculopathy. The trial will also assess the treatment's safety and durability.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Vabysmo
Vabysmo is an injected eye medicine used to treat vision loss from abnormal blood vessels in wet age-related macular degeneration and diabetic eye swelling.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Faricimab
Faricimab reduces abnormal blood vessel growth and leakage in the eye to help preserve vision in retinal vascular diseases.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
ASST Fatebenefratelli Sacco
ASST-Fatebenefratelli-Sacco
Baranzate, Italy
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Dipartimento Chirurgico, SSD Oftalmologia
Milan, Italy
Multimedica S.p.A.
Medical Retina Service, Operative Unit Ophthalmology
Milan, Italy

Sponsor: Association For Innovation And Biomedical Research On Light And Image
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.